GLP-1 drugs connected to brain disorder

A new study warns of a rare but serious neurological condition, Wernicke encephalopathy, potentially linked to GLP-1 weight-loss medications like Ozempic, Wegovy, Mounjaro, and Zepbound. Fifteen cases were identified through adverse event reports, most involving gastrointestinal symptoms and nutritional deficiencies that can lead to neurological damage if untreated. Experts emphasize that while the condition appears more common among users of these drugs, causation is not proven, and patients should seek medical guidance if experiencing persistent symptoms.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل